Combining Cognitive Behavioral Therapy with Brain Stimulation for OCD Treatment
Official title: A Randomized, Double-Blind, Clinical Trial to Study the Efficacy and Mechanisms of Transcranial Alternating Current Stimulation (tACS) Concurrent With Exposure-based Cognitive-Behavioral Therapy (CBT) for Obsessive-Compulsive Disorder (OCD)
Run by Shanghai Mental Health Center · NCT06717165 · Data updated 2026-11-12
This study is testing if combining a type of therapy called Cognitive Behavioral Therapy with a brain stimulation technique can help people with obsessive-compulsive disorder feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | April 15, 2024 |
| Main results expected | October 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 1, 2025 |
| Trial ID | NCT06717165 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-60 with a confirmed diagnosis of OCD and a Y-BOCS score of 16 or higher.
✕Probably not a fit
Patients with severe OCD symptoms that hinder assessment, those with serious medical or neurological conditions, or those currently on antiepileptic medication may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of combining exposure-based Cognitive Behavioral Therapy (CBT) with Transcranial Alternating Current Stimulation (tACS) in treating patients with obsessive-compulsive disorder (OCD). A total of 120 participants will be randomized into three groups: one receiving active tACS with CBT, another receiving sham tACS with CBT, and a waiting list group. The treatment will consist of 10 sessions over two months, with assessments of OCD symptoms and EEG monitoring to explore the neural mechanisms involved. The goal is to determine if the combination of tACS and CBT enhances treatment outcomes for OCD patients.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment outcomes for patients with OCD.
How similar studies have gone: While the combination of CBT and tACS is a novel approach, previous studies have shown promise in using tACS for various neurological and psychiatric conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
The investigators recruited outpatient adults with OCD confirmed by the Mini-International Neuropsychiatric Interview (MINI). The following inclusion and exclusion criteria were also applied: Inclusion Criteria: * 18-60 years old * With at least 9 years of education * Y-BOCS score ≥16 * No history of serious medical, neurological illness or other psychotic disorders other than OCD (anxiety or mild to moderate depression secondary to OCD was not exclusionary) * Medication-free or had received stable medication for at least 8 weeks before entering the study and continued the same medication throughout the study Exclusion Criteria: * History of serious medical, neurological illness or other psychotic disorders other than OCD * OCD symptoms are severe, preventing the patient from completing the required assessment and examination * Serious suicide risk * Women who are pregnant or planning to become pregnant * Currently taking antiepileptic medication * Clinically significant physical illnesses or laboratory test abnormalities that have clinical significance * Previous completion of a full course of CBT/ERP treatment
Where it's running
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Zhen Wang, PhD, MD — Shanghai Mental Health Center
- Study coordinator: Zhen Wang, PhD, MD
- Email: wangzhen@smhc.org.cn
- Phone: +86 34773516
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
Safety and feasibility of a next-generation dome helmet for neuromodulation in OCD
This study tests whether a new focused ultrasound helmet can safely help people with treatment-refractory OCD see if their symptoms improve.
-
Bergen Four-Day Treatment for OCD, in Finland
This trial tests whether the Bergen Four-Day Treatment for OCD can be implemented in Finnish psychiatric care to help people with OCD see if the intensive program works in a real-world setting.
-
Test different deep TMS coils and targets to treat OCD
This study tests whether different deep TMS coils and brain targets help reduce OCD symptoms in adults with OCD, using a double-blind setup with sham and active stimulation.
-
Role of theta brain waves in how kids control thoughts and actions
This study tests whether theta-frequency brain activity can reveal how children with ADHD or OCD, and healthy kids, manage thinking and behavior during tasks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.